Advertisement

COVID-19 sub-strain JN.1 found in Kerala woman

The sample from a 79-year-old woman had returned a positive result in an RT-PCR test on November 18, they said, adding that she had mild symptoms of influenza-like illnesses (ILI) and had recovered from COVID-19

Advertisement
FP Staff|Dec 16, 2023, 13:30:34 IST

A case of COVID-19 sub-variant JN.1 was detected in Kerala on December 8, official sources said on Saturday. The sample from a 79-year-old woman had returned a positive result in an RT-PCR test on November 18, they said, adding that she had mild symptoms of influenza-like illnesses (ILI) and had recovered from COVID-19.

Advertisement

More than 90 per cent of the COVID-19 cases in India at present are mild and they are in home isolation, the sources said.

Earlier, an Indian traveller was also detected with JN.1 sub-variant in Singapore. The person was a native of Tamil Nadu’s Tiruchirapalli district and had travelled to Singapore on October 25.

indiaMore from India

No increase in cases was observed in Tiruchirapalli district or other places in Tamil Nadu following the strain being detected in them. “No other case of JN.1 variant has been detected in India,” the source said.

The JN.1 sub-variant -- first identified in Luxembourg and since spreading to several countries -- is a descendant of the Pirola variant (BA.2.86). It contains a significant number of unique mutations, particularly in the spike protein, that may contribute to increased infectivity and immune evasion, a source explained.

Advertisement

However, initial data suggests that updated vaccines and treatments will still offer protection against JN.1 sub-strain, the source stated.

This sub-variant's resemblance to earlier sub-strains with distinct spike proteins is also noteworthy. Most of the changes in JN.1 sub-variant are found in the spike protein, which likely correlates to increases in infectivity and immune evasion.

Globally, 3,608 cases of BA.2.86 and its sub-variants have been reported mostly from Europe and North America.

The US Center for Disease Control and Prevention (CDC), however, said initial data suggest that updated COVID-19 vaccines will help protect against JN.1 sub-strain. It also said an analysis from the federal government's SARS-CoV-2 Interagency Group suggests treatments and testing will remain effective, they said.

Handpicked stories, in your inbox
Global stories. Indian perspective. Zero noise.
No Spam. Unsubscribe Any Time.
First Published:Dec 16, 2023, 13:25:23 IST
Advertisement
Advertisement
Trending Stories

Delhi, Bengaluru, Hyderabad... Neet paper leak protest spreads nationwide even as govt reaches out to CJP, Opposition

Protests over the alleged NEET paper leak intensified across multiple cities, while the Centre signalled talks with the Opposition and the Cockroach Janta Party. The Delhi High Court also stepped in, seeking preservation of CCTV footage related to police action.
3 min read
Advertisement
Advertisement
Up Next